Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors
Drug Saf 2018 Apr; 41(4):357–61 DOI: 10.1007/s40264-017-0622-2
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Drug Saf 2018 Apr; 41(4):357–61 DOI: 10.1007/s40264-017-0622-2
Arthritis Res Ther 2018; 20(1):60 doi: 10.1186/s13075-018-1539-6
Rheumatol Ther 2018 Jun; 5(1):283–91
Arthritis Rheumatol. 2017 Sep;69(9):1751-1761. doi: 10.1002/art.40176
Adv Ther. 2017 Aug;34(8):1936-1952. doi: 10.1007/s12325-017-0578-8
Arthritis Care Res (Hoboken). 2017 Oct;69(10):1484-1494. doi: 10.1002/acr.23303
Rheumatology. Doi 10.1093/rheumatology/kex068
J Manag Care Spec Pharm. 2016 Dec;22(12):1457-1471.
Arthritis Rheumatol. 2016 May 17. DOI 10.1002/art.39761 [Epub ahead of print]
Ann Rheum Dis. 2016 Apr 25;0:1–5 doi: 10.1136/annrheumdis-2016-209131